{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:03:11Z","timestamp":1790755391019,"version":"4.1.0"},"publisher-location":"New York, NY","reference-count":20,"publisher":"Springer US","isbn-type":[{"value":"9781071656068","type":"print"},{"value":"9781071656075","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2027]]},"DOI":"10.1007\/978-1-0716-5607-5_5","type":"book-chapter","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:46:43Z","timestamp":1790754403000},"page":"53-62","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunophenotyping of Human Regulatory T-Cells from Peripheral Blood Mononuclear Cells"],"prefix":"10.1007","author":[{"given":"Maria","family":"Lopez-Ocasio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Chi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Hockman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyvan","family":"Keyvanfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep K.","family":"Dagur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"issue":"9","key":"5_CR1","doi-asserted-by":"publisher","first-page":"a007021","DOI":"10.1101\/cshperspect.a007021","volume":"4","author":"C Benoist","year":"2012","unstructured":"Benoist C, Mathis D (2012) Treg cells, life history, and diversity. Cold Spring Harb Perspect Biol 4(9):a007021. https:\/\/doi.org\/10.1101\/cshperspect.a007021","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"5_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1365-2249.2008.03810.x","volume":"154","author":"JM Lawson","year":"2008","unstructured":"Lawson JM, Tremble J, Dayan C, Beyan H, Leslie RD, Peakman M, Tree TI (2008) Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes. Clin Exp Immunol 154(3):353\u20139. https:\/\/doi.org\/10.1111\/j.1365-2249.2008.03810.x","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"5_CR3","doi-asserted-by":"publisher","first-page":"7350","DOI":"10.4049\/jimmunol.181.10.7350","volume":"181","author":"A Schneider","year":"2008","unstructured":"Schneider A, Rieck M, Sanda S, Pihoker C, Greenbaum C, Buckner JH (2008) The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells. J Immunol 181(10):7350\u20135. https:\/\/doi.org\/10.4049\/jimmunol.181.10.7350","journal-title":"J Immunol"},{"issue":"6","key":"5_CR4","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s10753-012-9496-8","volume":"35","author":"N Yu","year":"2012","unstructured":"Yu N, Li X, Song W, Li D, Yu D, Zeng X, Li M, Leng X, Li X (2012) CD4(+)CD25 (+)CD127 (low\/-) T cells: a more specific Treg population in human peripheral blood. Inflammation 35(6):1773\u201380. https:\/\/doi.org\/10.1007\/s10753-012-9496-8","journal-title":"Inflammation"},{"issue":"24","key":"5_CR5","doi-asserted-by":"publisher","first-page":"20026","DOI":"10.18632\/oncotarget.4771","volume":"6","author":"E Elkord","year":"2015","unstructured":"Elkord E, Abd Al Samid M, Chaudhary B (2015) Helios, and not FoxP3, is the marker of activated Tregs expressing GARP\/LAP. Oncotarget 6(24):20026\u201336. https:\/\/doi.org\/10.18632\/oncotarget.4771","journal-title":"Oncotarget"},{"issue":"1","key":"5_CR6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4049\/jimmunol.1501704","volume":"196","author":"M Sebastian","year":"2016","unstructured":"Sebastian M, Lopez-Ocasio M, Metidji A, Rieder SA, Shevach EM, Thornton AM (2016) Helios controls a limited subset of regulatory T cell functions. J Immunol 196(1):144\u201355. https:\/\/doi.org\/10.4049\/jimmunol.1501704","journal-title":"J Immunol"},{"issue":"1","key":"5_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-02816-z","volume":"15","author":"M Ahn","year":"2025","unstructured":"Ahn M, Dostal J, Hegde P, Lee DJ (2025) CTLA-4 expression on Tregs is needed for suppression of autoimmune uveitis. Sci Rep 15(1):17745. https:\/\/doi.org\/10.1038\/s41598-025-02816-z","journal-title":"Sci Rep"},{"issue":"1","key":"5_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4049\/jimmunol.0803474","volume":"185","author":"H Moncrieffe","year":"2010","unstructured":"Moncrieffe H, Nistala K, Kamhieh Y, Evans J, Eddaoudi A, Eaton S, Wedderburn LR (2010) High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population. J Immunol 185(1):134\u201343. https:\/\/doi.org\/10.4049\/jimmunol.0803474","journal-title":"J Immunol"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"914799","DOI":"10.3389\/fimmu.2022.914799","volume":"13","author":"M Da","year":"2022","unstructured":"Da M, Chen L, Enk A, Ring S, Mahnke K (2022) The multifaceted actions of CD73 during development and suppressive actions of regulatory T cells. Front Immunol 13:914799. https:\/\/doi.org\/10.3389\/fimmu.2022.914799","journal-title":"Front Immunol"},{"issue":"12","key":"5_CR10","doi-asserted-by":"publisher","first-page":"14083","DOI":"10.18632\/oncotarget.7334","volume":"7","author":"M Abd Al Samid","year":"2016","unstructured":"Abd Al Samid M, Chaudhary B, Khaled YS, Ammori BJ, Elkord E (2016) Combining FoxP3 and Helios with GARP\/LAP markers can identify expanded Treg subsets in cancer patients. Oncotarget 7(12):14083\u201394. https:\/\/doi.org\/10.18632\/oncotarget.7334","journal-title":"Oncotarget"},{"issue":"6","key":"5_CR11","doi-asserted-by":"publisher","first-page":"103085","DOI":"10.1016\/j.autrev.2022.103085","volume":"21","author":"S Gertel","year":"2022","unstructured":"Gertel S, Polachek A, Elkayam O, Furer V (2022) Lymphocyte activation gene-3 (LAG-3) regulatory T cells: an evolving biomarker for treatment response in autoimmune diseases. Autoimmun Rev 21(6):103085","journal-title":"Autoimmun Rev"},{"issue":"3","key":"5_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nri3158","volume":"12","author":"HT Maecker","year":"2012","unstructured":"Maecker HT, McCoy JP, Nussenblatt R (2012) Standardizing immunophenotyping for the human immunology project. Nat Rev Immunol 12(3):191\u2013200. https:\/\/doi.org\/10.1038\/nri3158","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"5_CR13","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00262-015-1729-x","volume":"64","author":"SJ Santegoets","year":"2015","unstructured":"Santegoets SJ, Dijkgraaf EM, Battaglia A, Beckhove P, Britten CM, Gallimore A, Godkin A, Gouttefangeas C, de Gruijl TD, Koenen HJ, Scheffold A, Shevach EM, Staats J, Task\u00e9n K, Whiteside TL, Kroep JR, Welters MJ, van der Burg SH (2015) Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry. Cancer Immunol Immunother 64(10):1271\u201386. https:\/\/doi.org\/10.1007\/s00262-015-1729-x","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"5_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/cyto.a.21158","volume":"81","author":"A Biancotto","year":"2012","unstructured":"Biancotto A, Dagur PK, Fuchs JC, Langweiler M, McCoy Jr JP (2012) OMIP-004: in-depth characterization of human T regulatory cells. Cytometry A 81(1):15\u20136. https:\/\/doi.org\/10.1002\/cyto.a.21158","journal-title":"Cytometry A"},{"issue":"3","key":"5_CR15","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/cyto.a.23704","volume":"95","author":"J Nowatzky","year":"2019","unstructured":"Nowatzky J, Stagnar C, Manches O (2019) OMIP-053: identification, classification, and isolation of major FoxP3 expressing human CD4+ Treg subsets. Cytometry A. 95(3):264\u2013267. https:\/\/doi.org\/10.1002\/cyto.a.23704","journal-title":"Cytometry A."},{"issue":"1","key":"5_CR16","doi-asserted-by":"publisher","first-page":"298","DOI":"10.4049\/jimmunol.1501069","volume":"196","author":"R Vicente","year":"2016","unstructured":"Vicente R, Quentin J, Mausset-Bonnefont AL, Chuchana P, Martire D, Cren M, Jorgensen C, Louis-Plence P (2016) Nonclassical CD4+CD49b+ regulatory T cells as a better alternative to conventional CD4+CD25+ T cells to dampen arthritis severity. J Immunol 196(1):298\u2013309. https:\/\/doi.org\/10.4049\/jimmunol.1501069","journal-title":"J Immunol"},{"issue":"3","key":"5_CR17","doi-asserted-by":"publisher","first-page":"e59545","DOI":"10.1371\/journal.pone.0059545","volume":"8","author":"D Hu","year":"2013","unstructured":"Hu D, Weiner HL, Ritz J (2013) Identification of cytolytic CD161- CD56+ regulatory CD8 T cells in human peripheral blood. PLoS One 8(3):e59545. https:\/\/doi.org\/10.1371\/journal.pone.0059545","journal-title":"PLoS One"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"108418","DOI":"10.1016\/j.clim.2020.108418","volume":"215","author":"J Mitchell","year":"2020","unstructured":"Mitchell J, Kelly J, Kvedaraite E, von Bahr Greenwood T, Henter JI, Pellicci DG, Berzins SP, Kannourakis G (2020) Foxp3+ Tregs from Langerhans cell histiocytosis lesions co-express CD56 and have a definitively regulatory capacity. Clin Immunol  215:108418","journal-title":"Clin Immunol"},{"issue":"11","key":"5_CR19","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3390\/cells13110941","volume":"13","author":"C Gootjes","year":"2024","unstructured":"Gootjes C, Zwaginga JJ, Roep BO, Nikolic T (2024) Defining human regulatory T cells beyond FOXP3: the need to combine phenotype with function. Cells 13(11):941. https:\/\/doi.org\/10.3390\/cells13110941","journal-title":"Cells"},{"issue":"15","key":"5_CR20","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1158\/1078-0432.CCR-16-3192","volume":"23","author":"X Feng","year":"2017","unstructured":"Feng X, Zhang L, Acharya C, An G, Wen K, Qiu L, Munshi NC, Tai YT, Anderson KC (2017) Targeting CD38 suppresses induction and function of T regulatory cells to mitigate immunosuppression in multiple myeloma. Clin Cancer Res 23(15):4290\u20134300. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-3192","journal-title":"Clin Cancer Res"}],"container-title":["Methods in Molecular Biology","Immunophenotyping"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5607-5_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:46:43Z","timestamp":1790754403000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5607-5_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"ISBN":["9781071656068","9781071656075"],"references-count":20,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5607-5_5","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"1 October 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}